Rapid responses are electronic comments to the editor. They enable our users to debate issues raised in articles published on bmj.com. A rapid response is first posted online. If you need the URL (web address) of an individual response, simply click on the response headline and copy the URL from the browser window. A proportion of responses will, after editing, be published online and in the print journal as letters, which are indexed in PubMed. Rapid responses are not indexed in PubMed and they are not journal articles. The BMJ reserves the right to remove responses which are being wilfully misrepresented as published articles.
Medicines, Pharmacy and Industry are under one roof in the Department
of Health - this in itself leads to conflict of interest and priorities.
Health Policy is asking for dual delivery of efficiencies and quality
(productivity) in terms of optimising outcomes from medicines, one of the
most frequently made interventions in the NHS. Yet in the same department
in DH decisions are made about pricing of drugs, and impact the
pharmaceutical industry has on UK economy and its link to reference
Prior to any introduction of VBP, two issues need to be addressed -
that of health policy versus economic policy champions being under one
roof, and the governance surrounding orphan drugs.